Jove
Visualize
Contact Us

Related Experiment Videos

Anadys Pharmaceuticals, Inc.

Andre Basbaum1

  • 1Senior Manager, Corporate Development & Strategy, Anadys Pharmaceuticals, Inc., 9050 Camino Santa Fe, San Diego, CA 92121, USA. basbaum@anadyspharma.com

Pharmacogenomics
|July 2, 2003
PubMed
Summary

Anadys Pharmaceuticals is developing novel small molecule therapeutics for infectious diseases like hepatitis C and bacterial infections. Their lead hepatitis C program is in Phase IB clinical trials, utilizing advanced technologies for drug discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Adherence to international pharmacogenomic recommendations in pediatric cancer care: a cohort analysis embedded within the MARVEL-PIC randomized trial.

Pharmacogenomics·2026
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmaceutical Sciences
  • Infectious Diseases
  • Drug Discovery

Background:

  • Anadys Pharmaceuticals is dedicated to advancing patient care through the development of novel anti-infective medicines.
  • The company focuses on small molecule therapeutics for treating infectious diseases, including hepatitis C and bacterial infections.

Purpose of the Study:

  • To discover, develop, and commercialize potent anti-infective drug candidates.
  • To advance novel therapeutic programs targeting unmet needs in infectious disease treatment.

Main Methods:

  • Utilizing an integrated suite of technologies: Riboproteomics, ATLAS, and structure-based drug design.
  • Employing a world-class medicinal chemistry team for rapid lead compound optimization.
  • Conducting preclinical and clinical testing for drug candidates.

Main Results:

  • Lead hepatitis C program has advanced to Phase IB clinical testing.
  • A broad portfolio of antiviral and antibacterial programs targeting novel mechanisms of action is under development.

Conclusions:

  • Anadys possesses integrated capabilities for efficient drug discovery and development.
  • The company aims to build a robust pipeline of innovative anti-infective therapies to improve patient care.

Related Experiment Videos